Web12 dec. 2024 · Twenty-eight days after vaccination, the study participants were challenged intranasally with live RSV-A (strain Memphis 37b). During a 12-day follow-up period, significantly lower viral loads (p = 0.012) and symptomatology (p = 0.002) were observed in the vaccine group ( Figure 1 A ). Web26 sep. 2024 · Biological: RSV A Memphis 37b Study Type Interventional Enrollment (Anticipated) 105 Phase Phase 2 Contacts and Locations This section provides the …
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus …
Web19 jul. 2024 · MV-014-212 was attenuated and immunogenic in nonhuman primates producing both systemic and mucosal - immunity after one mucosal administration.A single mucosal administration of MV -014-212 in African green monkeys (AGMs) elicited neutralizing antibodies against the homologous virus and cross neutralizing activity … Web18 apr. 2024 · The AUC of RSV-A Memphis 37b viral load measured in nasopharyngeal swabs by qPCR (log10 copies/mL units) and by cell base infectivity assay (log10 … moncks corner nutrition
EudraCT Number 2024-003194-33 - EU Clinical Trials …
WebFind many great new & used options and get the best deals for 2024 Topps Tier One Nomar Garciaparra Tier One Talent Auto /125 Boston Red Sox at the best online prices at eBay! Free shipping for many products! Web7 dec. 2024 · In a recent study posted to the medRxiv* preprint server, researchers reported the immunogenicity, efficacy, and safety of the MVA-BN (modified vaccinia Ankara-Bavarian Nordic)-RSV (respiratory syncytial virus) vaccine against RSV-A (RSV subtype A) Memphis 37b strain in a human challenge trial. Study: Decreased Viral Load, Symptom Reduction, … Web1 feb. 2024 · In a two-part, phase 2a, randomized, double-blind, placebo-controlled challenge trial, we assigned participants who had been inoculated with RSV-A Memphis 37b to receive EDP-938 or placebo. Different doses of EDP-938 were assessed. Nasal-wash samples were obtained from day 2 until day 12 for assessments. ibm thinkcentre m50 8187